Related Experiment Video
Updated: Jun 27, 2026
05:12
Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
Published on: September 4, 2017
Imaging in multicentric Castleman's disease.
Robert Barker1, Fahrad Kazmi, Mark Bower
1Department of Oncology, Imperial College School of Medicine, London, UK.
Journal of HIV Therapy
|November 29, 2008
Summary
Multicentric Castleman disease (MCD) is a rare disorder often seen in HIV-1 patients. FDG PET-CT shows promise in monitoring MCD activity alongside other diagnostic tools.
Area of Science:
- Oncology
- Infectious Diseases
- Radiology
Background:
- Multicentric Castleman disease (MCD) is a rare lymphoproliferative disorder.
- It commonly presents with fever, anemia, and lymphadenopathy, particularly in individuals with HIV-1.
- Current diagnostic methods, including CT scans, lack sufficient reliability, necessitating histological confirmation.
Purpose of the Study:
- To evaluate newer imaging techniques for improved diagnostic accuracy in HIV-associated MCD.
- To explore the utility of FDG PET-CT in monitoring disease activity.
Main Methods:
- Review of preliminary findings on imaging techniques in patients with HIV-associated MCD.
- Comparison of FDG PET-CT with established clinical, laboratory, and virological markers (HHV-8 DNA viral load).
Main Results:
- CT scan findings are not definitive for MCD diagnosis.
- Preliminary data suggest FDG PET-CT may aid in monitoring MCD disease activity.
- FDG PET-CT complements traditional monitoring tools.
Conclusions:
- Histological confirmation remains essential for MCD diagnosis.
- FDG PET-CT shows potential as a valuable tool for monitoring disease activity in HIV-associated MCD.
- Integrated monitoring using clinical, laboratory, virological, and imaging data improves disease management.
